Singapore markets closed

Straits Times Index
3,264.53
-35.51(-1.08%)
S&P 500
5,187.70
+6.96(+0.13%)
Dow
38,884.26
+31.99(+0.08%)
Nasdaq
16,332.56
-16.69(-0.10%)
Bitcoin USD
62,162.17
-1,438.32(-2.26%)
CMC Crypto 200
1,322.39
+27.72(+2.14%)

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.5800

+0.0500

(+3.27%)

At close: 04:00PM EDT

Loading interactive chart…

Thomson Reuters StreetEvents
Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call
Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call
PR Newswire
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024. The company ended the quarter with $82 million in total assets, $54 million in total liabilities and $27 million of shareholders' equity.
PR Newswire
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024.